TickerFacts.

A business in context

XENE research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-07 · 8010 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-09-01 · 0001193125-26-382412

  2. 4 · Ownership change

    Report date 2026-08-28 · 0001193125-26-377309

  3. 4 · Ownership change

    Report date 2026-08-11 · 0001193125-26-349351

  4. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-338244

  5. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-338019 · Items 2.02,7.01,9.01

  6. 4 · Ownership change

    Report date 2026-06-05 · 0001193125-26-262672

  7. 4 · Ownership change

    Report date 2026-06-05 · 0001193125-26-262671

  8. 4 · Ownership change

    Report date 2026-06-01 · 0001193125-26-256126

  9. 4 · Ownership change

    Report date 2026-06-01 · 0001193125-26-256125

  10. 4 · Ownership change

    Report date 2026-06-01 · 0001193125-26-256124

  11. 8-K · Current report

    Report date 2026-06-02 · 0001193125-26-255396 · Items 5.02,5.07,9.01

  12. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-212153

  13. 8-K · Current report

    Report date 2026-05-07 · 0001193125-26-211843 · Items 2.02,7.01,9.01

  14. DEF 14A · Proxy statement

    Report date 2026-04-22 · 0001193125-26-170320

  15. 8-K · Current report

    Report date 2026-04-07 · 0001193125-26-152834 · Items 5.02,9.01

  16. 8-K · Current report

    Report date 2026-03-13 · 0001193125-26-106144 · Items 8.01,9.01

  17. 8-K · Current report

    Report date 2026-03-10 · 0001193125-26-104199 · Items 1.01,8.01,9.01

  18. 8-K · Current report

    Report date 2026-03-09 · 0001193125-26-097577 · Items 7.01,9.01

  19. 8-K · Current report

    Report date 2026-02-27 · 0001193125-26-082520 · Items 8.01,9.01

  20. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-076650

  21. 8-K · Current report

    Report date 2026-02-26 · 0001193125-26-076530 · Items 2.02,7.01,9.01

  22. 8-K · Current report

    Report date 2025-11-24 · 0001193125-25-303862 · Items 5.02,9.01

  23. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-262646

  24. 8-K · Current report

    Report date 2025-11-03 · 0001193125-25-262519 · Items 2.02,7.01,9.01

  25. 8-K/A · Current report

    Report date 2025-10-15 · 0001193125-25-242583 · Items 5.02,8.01,9.01

  26. 8-K · Current report

    Report date 2025-10-15 · 0001193125-25-241546 · Items 5.02

  27. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-106599

  28. 8-K · Current report

    Report date 2025-08-11 · 0000950170-25-106529 · Items 2.02,7.01,9.01

  29. 8-K · Current report

    Report date 2025-06-30 · 0000950170-25-093996 · Items 5.02

  30. 8-K · Current report

    Report date 2025-06-04 · 0000950170-25-082494 · Items 5.07,9.01

  31. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-069342

  32. 8-K · Current report

    Report date 2025-05-12 · 0000950170-25-069183 · Items 2.02,7.01,9.01

  33. DEF 14A · Proxy statement

    Report date 2025-04-24 · 0000950170-25-058086

  34. 8-K · Current report

    Report date 2025-03-14 · 0000950170-25-040381 · Items 8.01,9.01

  35. 8-K · Current report

    Report date 2025-03-03 · 0000950170-25-033653 · Items 4.01,9.01

  36. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-029149

  37. 8-K · Current report

    Report date 2025-02-24 · 0000950170-25-029010 · Items 2.02,5.02,7.01,9.01

  38. 8-K · Current report

    Report date 2025-01-17 · 0000950170-25-006495 · Items 5.02

  39. 10-Q · Quarterly report

    Report date 2024-09-30 · 0000950170-24-125547

  40. 8-K · Current report

    Report date 2024-11-12 · 0000950170-24-125374 · Items 2.02,7.01,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 2 transaction rows2SGrant / award: 14 transaction rows14AExercise / conversion: 16 transaction rows16MTax / exercise payment: 2 transaction rows2FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

34 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-05
2026-06-08
PATOU GARYS · Sale
Disposed
Common Shares1322.053.14
2026-06-05
2026-06-08
Cannon GillianS · Sale
Disposed
Common Shares1190.053.14
2026-06-03
2026-06-03
PATOU GARYA · Grant / award
Acquired
Restricted Share Units
Derivative security
1593.00.0
2026-06-03
2026-06-03
PATOU GARYA · Grant / award
Acquired
Share Option (Right to Buy)
Derivative security
10507.00.0
2026-06-03
2026-06-03
Machado PatrickA · Grant / award
Acquired
Restricted Share Units
Derivative security
1593.00.0
2026-06-03
2026-06-03
Machado PatrickA · Grant / award
Acquired
Share Option (Right to Buy)
Derivative security
10507.00.0
2026-06-03
2026-06-03
Gover Justin D.A · Grant / award
Acquired
Share Option (Right to Buy)
Derivative security
10507.00.0
2026-06-03
2026-06-03
Gover Justin D.A · Grant / award
Acquired
Restricted Share Units
Derivative security
1593.00.0
2026-06-03
2026-06-03
GAROFALO ELIZABETH A.A · Grant / award
Acquired
Share Option (Right to Buy)
Derivative security
10507.00.0
2026-06-03
2026-06-03
GAROFALO ELIZABETH A.A · Grant / award
Acquired
Restricted Share Units
Derivative security
1593.00.0
2026-06-03
2026-06-03
GANNON STEVENA · Grant / award
Acquired
Restricted Share Units
Derivative security
1593.00.0
2026-06-03
2026-06-03
GANNON STEVENA · Grant / award
Acquired
Share Option (Right to Buy)
Derivative security
10507.00.0
2026-06-03
2026-06-03
Cannon GillianA · Grant / award
Acquired
Restricted Share Units
Derivative security
1593.00.0
2026-06-03
2026-06-03
Cannon GillianA · Grant / award
Acquired
Share Option (Right to Buy)
Derivative security
10507.00.0
2026-06-03
2026-06-03
Svoronos DawnA · Grant / award
Acquired
Share Option (Right to Buy)
Derivative security
10507.00.0
2026-06-03
2026-06-03
Svoronos DawnA · Grant / award
Acquired
Restricted Share Units
Derivative security
1593.00.0
2026-06-01
2026-06-03
PATOU GARYM · Exercise / conversion
Acquired
Common Shares2645.0—
2026-06-01
2026-06-03
PATOU GARYM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2645.00.0
2026-06-01
2026-06-03
Machado PatrickM · Exercise / conversion
Acquired
Common Shares2645.0—
2026-06-01
2026-06-03
Machado PatrickM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2645.00.0
2026-06-01
2026-06-03
Gover Justin D.M · Exercise / conversion
Acquired
Common Shares2645.0—
2026-06-01
2026-06-03
Gover Justin D.M · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2645.00.0
2026-06-01
2026-06-03
GAROFALO ELIZABETH A.M · Exercise / conversion
Acquired
Common Shares2645.0—
2026-06-01
2026-06-03
GAROFALO ELIZABETH A.M · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2645.00.0
2026-06-01
2026-06-03
GANNON STEVENF · Tax / exercise payment
Disposed
Common Shares1416.053.41
2026-06-01
2026-06-03
GANNON STEVENM · Exercise / conversion
Acquired
Common Shares2645.0—
2026-06-01
2026-06-03
GANNON STEVENM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2645.00.0
2026-06-01
2026-06-03
Cannon GillianM · Exercise / conversion
Acquired
Common Shares2645.0—
2026-06-01
2026-06-03
Cannon GillianM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2645.00.0
2026-06-01
2026-06-03
Svoronos DawnM · Exercise / conversion
Acquired
Common Shares2645.0—
2026-06-01
2026-06-03
Svoronos DawnF · Tax / exercise payment
Disposed
Common Shares1416.053.41
2026-06-01
2026-06-03
Svoronos DawnM · Exercise / conversion
Disposed
Restricted Share Units
Derivative security
2645.00.0
2026-05-12
2026-05-13
GANNON STEVENM · Exercise / conversion
Acquired
Common Shares3500.07.38
2026-05-12
2026-05-13
GANNON STEVENM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
3500.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001582313Xenon Pharmaceuticals Inc.

No parent relationship is available in this import; this is not proof of independence.

Legal Entity Identifier
549300XV44Q9Z1MIPQ03
GLEIF legal name
Xenon Pharmaceuticals Inc.
Entity / LEI registration status
ACTIVE / LAPSED
Reference data updated
2023-08-08T17:57:43Z

direct-parent: no parent LEI supplied

ultimate-parent: no parent LEI supplied

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Xenon Pharmaceuticals · alias · wikidata
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$0$0
2023-12-31$0$0
2022-12-31$9.43M$10.76M
2021-12-31$18.44M$22.72M
2020-12-31$32.17M$41.50M
2019-12-31$6.83M$8.92M

Bureau of Labor Statistics · retrieved 2026-09-07 · 9 selected series; gaps remain missing

Explore the CPI history ↗